Skip Navigation


Annals of Oncology Advance Access originally published online on January 21, 2008
Annals of Oncology 2008 19(3):595; doi:10.1093/annonc/mdm602
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/3/595    most recent
mdm602v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dietrich, P.-Y.
Right arrow Articles by Duchosal, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dietrich, P.-Y.
Right arrow Articles by Duchosal, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

letters to the editor

Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome

The first 10% of the full text of this article appears below.

POEMS is an acronym for a rare multisystemic syndrome encompassing polyneuropathy (P), organomegaly (O), endocrinopathy (E), monoclonal gammopathy (M), skin changes (S) and additional features variably expressed [1]. POEMS syndrome is associated with high vascular endothelial growth factor (VEGF) . . . [Full Text of this Article]

P.-Y. Dietrich1,* and M. A. Duchosal2

1 Service of Oncology, University Hospital, Geneva
2 Service of Hematology, University Hospital, Lausanne, Switzerland

* (E-mail: pierre-yves.dietrich@hcuge.ch)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NDT PlusHome page
J. Guitard, A. Pillet, M. Soubrier, A. Modesto, and D. Chauveau
Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring
NDT Plus, October 1, 2009; 2(5): 357 - 359.
[Abstract] [Full Text] [PDF]